| Followers | 1129 |
| Posts | 32730 |
| Boards Moderated | 2 |
| Alias Born | 01/11/2016 |
Wednesday, June 05, 2024 11:20:11 PM
No, we are on the same page, I thought you said NOL's can be utilized on any sector, yes if it is energy they can't utilize the NOL's but if it is biotech they can utilize it. But also read the filings that they don't plan on using the NOL's on their last annual report, but also in discussion with acquisition targets but nothing has been determined yet. Also what makes you think this could be the acquisition target?
https://www.pharmaceutical-technology.com/data-insights/ambroxol-belrose-pharma-gaucher-disease-type-i-likelihood-of-approval/?cf-view
https://www.pharmaceutical-technology.com/data-insights/ambroxol-belrose-pharma-gaucher-disease-type-i-likelihood-of-approval/?cf-view
Recent ENZN News
- Enzon Announces Completion of the Exchange Offer Relating to Series C Non-Convertible Redeemable Preferred Stock • GlobeNewswire Inc. • 03/25/2026 12:45:00 PM
- Form 425 - Prospectuses and communications, business combinations • Edgar (US Regulatory) • 03/25/2026 12:38:31 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/25/2026 12:36:13 PM
- Form SC TO-I/A - Tender offer statement by Issuer: [Amend] • Edgar (US Regulatory) • 03/25/2026 12:33:16 PM
- Enzon Announces Reverse Stock Split • GlobeNewswire Inc. • 03/24/2026 12:45:00 PM
- Form SC TO-I/A - Tender offer statement by Issuer: [Amend] • Edgar (US Regulatory) • 03/24/2026 12:35:53 PM
- Form 8-A12G/A - Registration of securities [Section 12(g)]: [Amend] • Edgar (US Regulatory) • 03/24/2026 12:33:09 PM
- Form 425 - Prospectuses and communications, business combinations • Edgar (US Regulatory) • 03/24/2026 12:30:53 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/24/2026 12:30:15 PM
- Enzon Announces Extension of Exchange Offer Relating to Series C Non-Convertible Redeemable Preferred Stock • GlobeNewswire Inc. • 03/19/2026 08:30:00 PM
- Form 425 - Prospectuses and communications, business combinations • Edgar (US Regulatory) • 03/19/2026 08:18:45 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/19/2026 08:16:32 PM
- Form SC TO-I/A - Tender offer statement by Issuer: [Amend] • Edgar (US Regulatory) • 03/19/2026 08:07:03 PM
- Form 8-A12G/A - Registration of securities [Section 12(g)]: [Amend] • Edgar (US Regulatory) • 03/18/2026 12:52:08 PM
- Form 425 - Prospectuses and communications, business combinations • Edgar (US Regulatory) • 03/18/2026 12:48:14 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/18/2026 12:45:26 PM
- Form 425 - Prospectuses and communications, business combinations • Edgar (US Regulatory) • 03/16/2026 08:10:19 PM
- Enzon Announces Extension of Exchange Offer Relating to Series C Non-Convertible Redeemable Preferred Stock • GlobeNewswire Inc. • 03/16/2026 08:10:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/16/2026 08:05:43 PM
- Form SC TO-I/A - Tender offer statement by Issuer: [Amend] • Edgar (US Regulatory) • 03/16/2026 08:00:54 PM
- Enzon Announces Extension of Exchange Offer Relating to Series C Non-Convertible Redeemable Preferred Stock • GlobeNewswire Inc. • 03/11/2026 12:45:00 PM
- Form 8-A12G/A - Registration of securities [Section 12(g)]: [Amend] • Edgar (US Regulatory) • 03/11/2026 12:39:23 PM
- Form 425 - Prospectuses and communications, business combinations • Edgar (US Regulatory) • 03/11/2026 12:36:14 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/11/2026 12:34:49 PM
- Form SC TO-I/A - Tender offer statement by Issuer: [Amend] • Edgar (US Regulatory) • 03/11/2026 12:31:05 PM
